ea0087p14 | Poster Presentations | UKINETS2022
Porto Juliana
, Hayes Aimee
, Branton Alexander
, Caplin Martyn
, Alusi Martyn
, Grossman Ashley
Olfactory neuroblastoma (ONB) is a rare neuroendocrine tumour with a slow onset of symptoms, and classically a propensity for recurrence and a poor prognosis. Due to its rarity, there is no agreed standard therapy, but treatment will usually include surgical resection, adjuvant radiotherapy and/or chemotherapy. However, such tumours very often show positive uptake on somatostatin receptor radionuclide scanning, and selective use of peptide receptor radionuclide therapy (PRRT) ...